Literature DB >> 19459155

Cardiac potential of stem cells from whole human umbilical cord tissue.

Kai Hong Wu1, Xu Ming Mo, Bin Zhou, Shi Hong Lu, Shao Guang Yang, Ying Long Liu, Zhong Chao Han.   

Abstract

We investigated the role of stem cells from human umbilical cord tissue in cardiomyocyte regeneration. The umbilical cord stem cells were initially characterized and differentiated in a myocardial differentiation medium containing 5-azacytidine for 24 h. Differentiation into cardiomyocytes was determined by expression of cardiac specific markers, like cardiac alpha-actin, connexin43, myosin, Troponin T, and ultrastructural analysis. In vivo, the transplanted umbilical cord stem cells were sprouting from local injection and differentiated into cardiomyocyte-like cells in a rat myocardial infarction model. Echocardiography revealed increasing left ventricular function after umbilical cord stem cell transplantation. These results demonstrate that umbilical cord stem cells can differentiate into cardiomyocyte-like cells both in vitro and in vivo. Therefore, human umbilical cord might represent a source of stem cells useful for cellular therapy and myocardial tissue engineering. Future studies are required to determine the molecular signaling mechanisms responsible for this phenomenon. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19459155     DOI: 10.1002/jcb.22193

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

1.  In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells.

Authors:  Peter Szaraz; Yarden S Gratch; Farwah Iqbal; Clifford L Librach
Journal:  J Vis Exp       Date:  2017-08-09       Impact factor: 1.355

2.  Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study.

Authors:  Ranhua Jiang; Zhibo Han; Guangsheng Zhuo; Xiaodan Qu; Xue Li; Xin Wang; Yuankang Shao; Shimin Yang; Zhong Chao Han
Journal:  Front Med       Date:  2011-03-17       Impact factor: 4.592

3.  Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting.

Authors:  Alp Can; Ahmet Tulga Ulus; Ozgur Cinar; Ferda Topal Celikkan; Erdal Simsek; Mesut Akyol; Ugur Canpolat; Murat Erturk; Fadil Kara; Osman Ilhan
Journal:  Stem Cell Rev Rep       Date:  2015-10       Impact factor: 5.739

4.  Transplantation of placenta-derived mesenchymal stem cells in the EAE mouse model of MS.

Authors:  Yonit Fisher-Shoval; Yael Barhum; Ofer Sadan; Shlomit Yust-Katz; Tali Ben-Zur; Nirit Lev; Chen Benkler; Moshe Hod; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2012-05-26       Impact factor: 3.444

5.  5-Azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase.

Authors:  Qian Qian; Hui Qian; Xu Zhang; Wei Zhu; Yongmin Yan; Shengqin Ye; Xiujuan Peng; Wei Li; Zhe Xu; Lingyun Sun; Wenrong Xu
Journal:  Stem Cells Dev       Date:  2011-06-01       Impact factor: 3.272

6.  Reprogramming of human umbilical cord stromal mesenchymal stem cells for myogenic differentiation and muscle repair.

Authors:  Cetin Kocaefe; Deniz Balci; Burcu Balci Hayta; Alp Can
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

7.  Sphingosine-1-phosphate promotes the differentiation of human umbilical cord mesenchymal stem cells into cardiomyocytes under the designated culturing conditions.

Authors:  Zhenqiang Zhao; Zhibin Chen; Xiubo Zhao; Fang Pan; Meihua Cai; Tan Wang; Henggui Zhang; Jian R Lu; Ming Lei
Journal:  J Biomed Sci       Date:  2011-06-07       Impact factor: 8.410

Review 8.  Stem cell therapy and tissue engineering for correction of congenital heart disease.

Authors:  Elisa Avolio; Massimo Caputo; Paolo Madeddu
Journal:  Front Cell Dev Biol       Date:  2015-06-30

9.  Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model.

Authors:  Hiranmoy Das; Jon C George; Matthew Joseph; Manjusri Das; Nasreen Abdulhameed; Anna Blitz; Mahmood Khan; Ramasamy Sakthivel; Hai-Quan Mao; Brian D Hoit; Periannan Kuppusamy; Vincent J Pompili
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

Review 10.  Mesenchymal stem cells from umbilical cord tissue as potential therapeutics for cardiomyodegenerative diseases - a review.

Authors:  Trixi Hollweck; Christian Hagl; Günther Eissner
Journal:  Int J Mol Cell Med       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.